阿莫伦特 T2613

Product Introduction
Bioactivity


英文名: Almorexant

描述: Almorexant (ACT 078573) 是一种有效的竞争性食欲素 1 受体 (OX1)/食欲素 2 受体 (OX2) 双重拮抗剂，OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 45 mg/mL (87.79 mM)


关键字: pancreatic cancer | Orexin Receptor (OX Receptor) | Pancreatic ductal adenocarcinoma | Cataplexy | HCRT Receptor | Inhibitor | Almorexant | ACT078573 | Apoptosis | GPCR | orexin | Hypocretin Receptor | Ca2+ channels | narcolepsy | Caspase | HPAF-II cells | ACT-078573 | AsPC-1 cells | Calcium Channel | Ca channels | hypocretin | inhibit | PDAC

相关产品: Seltorexant | TCS 1102 | PF3274167 | TCS-OX2-29 | DORA-22 | OXA (17-33) acetate | Almorexant hydrochloride | SB-408124 | ACT-462206 | MK-3697

相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | GPCR Compound Library | Orally Active Compound Library | NO PAINS Compound Library

阿莫伦特 T2613信息由TargetMol中国为您提供，如您想了解更多关于阿莫伦特 T2613报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途